Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9712)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 28, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zopf S, Kremer AE, Neurath MF, Siebler J. Advances in hepatitis C therapy: What is the current state - what come’s next? World J Hepatol 2016; 8(3): 139-147 [PMID: 26839638 DOI: 10.4254/wjh.v8.i3.139] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i3/139.htm |
| Number | Citing Articles |
| 1 |
C. Nelson Hayes, Kazuaki Chayama. Interferon stimulated genes and innate immune activation following infection with hepatitis B and C viruses. Journal of Medical Virology 2017; 89(3): 388 doi: 10.1002/jmv.24659
|
| 2 |
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. Journal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
|
| 3 |
Allison M. Bell, Jamie L. Wagner, Katie E. Barber, Kayla R. Stover. Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C. International Journal of Hepatology 2016; 2016: 1 doi: 10.1155/2016/3852126
|
| 4 |
Hong-Tao Xu, Said A. Hassounah, Susan P. Colby-Germinario, Maureen Oliveira, Clare Fogarty, Yudong Quan, Yingshan Han, Olga Golubkov, Ilinca Ibanescu, Bluma Brenner, Brent R. Stranix, Mark A. Wainberg. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors. Journal of Antimicrobial Chemotherapy 2017; : dkw514 doi: 10.1093/jac/dkw514
|
| 5 |
Suzanne JF Kaptein, Johan Neyts. Towards antiviral therapies for treating dengue virus infections. Current Opinion in Pharmacology 2016; 30: 1 doi: 10.1016/j.coph.2016.06.002
|
| 6 |
Charles B Nguyen, Courtney W Houchen, Naushad Ali. APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases. Experimental Biology and Medicine 2017; 242(3): 242 doi: 10.1177/1535370216672746
|
| 7 |
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmunity Reviews 2016; 15(12): 1145 doi: 10.1016/j.autrev.2016.09.006
|
| 8 |
|
| 9 |
Sarah Bauerle Bass, Amy Jessop, Laurie Maurer, Muhamed Gashat, Mohammed Al Hajji, Mercedes Gutierrez. Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development. Journal of Health Communication 2018; 23(1): 117 doi: 10.1080/10810730.2017.1414902
|
| 10 |
Veronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis De Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo1O, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens, Yot Teerawattananon, Ellen ‘t Hoen, Anita K Wagner, Prashant Yadav, Michael R Reich. Essential medicines for universal health coverage. Kazan medical journal 2019; 100(1): 4 doi: 10.17816/KMJ2019-4
|
| 11 |
Yash Mittal, AnnMarie Liapakis, Joseph K. Lim. Treatment of chronic hepatitis C virus infection in patients with end‐stage renal disease on hemodialysis. Clinical Liver Disease 2016; 8(3): 76 doi: 10.1002/cld.575
|
| 12 |
F Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, T Lott, R Felder, S J Scotland, T S K Eisinger-Mathason, H Brem, B Tyler, N Skuli. Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic. Oncogene 2017; 36(21): 3037 doi: 10.1038/onc.2016.457
|
| 13 |
Yvonne Chasser, Arthur Y. Kim, Oliver Freudenreich. Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era. Psychosomatics 2017; 58(1): 1 doi: 10.1016/j.psym.2016.09.004
|
| 14 |
Wataru Ito, Masaaki Toyama, Mika Okamoto, Masanori Ikeda, Koichi Watashi, Takaji Wakita, Yuichi Hashimoto, Masanori Baba. Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivative. Antiviral Chemistry and Chemotherapy 2015; 24(5-6): 148 doi: 10.1177/2040206616663956
|
| 15 |
Anthony Nardone, Lina Nerlander, Erika Duffell, Marta Valenciano, Maria Buti, Cristina Marcos-Fosch, Tatjana Nemeth-Blažić, Odette Popovici, Adriana Vince, Petruta Violeta Filip, Tajana Filipec, Mirjana Lana Kosanović Ličina, Boris Luksic, Diana Nonković, Corina Silvia Pop, Fabiana Radu, Irina Teodorescu, Adriana Violeta Topan. A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019.
Eurosurveillance 2023; 28(6) doi: 10.2807/1560-7917.ES.2023.28.6.2200184
|
| 16 |
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020; doi: 10.1017/9781316823026
|
| 17 |
Giada Sebastiani, Nicole Wilkinson, Kostas Pantopoulos. Pharmacological Targeting of the Hepcidin/Ferroportin Axis. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00160
|
| 18 |
Guglielmo Borgia, Alberto Enrico Maraolo, Salvatore Nappa, Ivan Gentile, Antonio Riccardo Buonomo. NS5B polymerase inhibitors in phase II clinical trials for HCV infection. Expert Opinion on Investigational Drugs 2018; 27(3): 243 doi: 10.1080/13543784.2018.1420780
|
| 19 |
Nowlan Selvapatt, Ashley Brown. A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapies. F1000Research 2016; 5: 2061 doi: 10.12688/f1000research.9114.1
|
| 20 |
Steffen Zopf, Lara Rösch, Peter C. Konturek, Ruediger S. Goertz, Markus F. Neurath, Deike Strobel. Low Pretreatment Acoustic Radiation Force Impulse Imaging (ARFI) Values Predict Sustained Virological Response in Antiviral Hepatitis C Virus (HCV) Therapy. Medical Science Monitor 2016; 22: 3500 doi: 10.12659/MSM.896344
|
| 21 |
Sarah Bauerle Bass, Amy Jessop, Muhamed Gashat, Laurie Maurer, Mohammed Alhajji, Jon Forry. Take Charge, Get Cured: The development and user testing of a culturally targeted mHealth decision tool on HCV treatment initiation for methadone patients. Patient Education and Counseling 2018; 101(11): 1995 doi: 10.1016/j.pec.2018.07.007
|
| 22 |
Aoife McCarthy, Kieran Sheahan. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020; : 65 doi: 10.1017/9781316823026.006
|
| 23 |
Gislaine Silveira Olm. Dermatology in Public Health Environments. 2023; : 1285 doi: 10.1007/978-3-031-13505-7_50
|
| 24 |
L. Couronné, E. Bachy, S. Roulland, B. Nadel, F. Davi, M. Armand, D. Canioni, J.M. Michot, C. Visco, L. Arcaini, C. Besson, O. Hermine. From hepatitis C virus infection to B-cell lymphoma. Annals of Oncology 2018; 29(1): 92 doi: 10.1093/annonc/mdx635
|
| 25 |
Tarik Asselah, Stefan Bourgeois, Stephen Pianko, Stefan Zeuzem, Mark Sulkowski, Graham R. Foster, Lingling Han, John McNally, Anu Osinusi, Diana M. Brainard, G. Mani Subramanian, Edward J. Gane, Jordan J. Feld, Alessandra Mangia. Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1‐6 and compensated cirrhosis or advanced fibrosis. Liver International 2018; 38(3): 443 doi: 10.1111/liv.13534
|
| 26 |
Reza Taherkhani, Fatemeh Farshadpour. Lurking epidemic of hepatitis C virus infection in Iran: A call to action. World Journal of Hepatology 2017; 9(24): 1040-1042 doi: 10.4254/wjh.v9.i24.1040
|
| 27 |
Ryo Takuma, Toshiya Morozumi, Yuko Yamamoto, Takashi Kobayashi, Takaaki Matsui, Masato Yoneda, Takaomi Kessoku, Asako Nogami, Muneaki Tamura, Yohei Kamata, Shuntaro Sugihara, Yoshiaki Nomura, Masahiro To, Masato Minabe, Kenji Mitsudo, Atsushi Nakajima, Motohiro Komaki. Association between Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma and Periodontopathic Bacteria: A Cross-Sectional Pilot Study. Applied Sciences 2023; 13(6): 3893 doi: 10.3390/app13063893
|
| 28 |
Ilaria Izzo, Paola Zanotti, Claudia Chirico, Salvatore Casari, Vincenzo Villanacci, Marianna Salemme, Luciano Biasi, Elena Festa, Francesco Castelli. Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C. Infection 2016; 44(6): 811 doi: 10.1007/s15010-016-0915-x
|
| 29 |
Alice Sanna, Yann Le Strat, Françoise Roudot-Thoraval, Sylvie Deuffic Burban, Patrizia Carrieri, Elisabeth Delarocque-Astagneau, Christine Larsen. Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.
Eurosurveillance 2017; 22(30) doi: 10.2807/1560-7917.ES.2017.22.30.30582
|
| 30 |
Edward Tam, Julie Tremblay, Chris Fraser, Brian Conway, Alnoor Ramji, Sergio Borgia, Keith Tsoi, Eric M Yoshida, Bahe Rajendran, Gisela Macphail, Alexander Wong, Curtis Cooper, Keyur Patel, Marco Puglia, Kris Stewart, Benoit Trottier, Lucie Deshaies, Karen Doucette, Peter Ghali, Samuel S Lee, Jodi Halsey-Brandt, Janie B Trepanier. The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis C. Canadian Liver Journal 2020; 3(3): 251 doi: 10.3138/canlivj-2019-0029
|
| 31 |
Gislaine Silveira Olm. Dermatology in Public Health Environments. 2018; : 823 doi: 10.1007/978-3-319-33919-1_40
|
| 32 |
Tomoko Tadokoro, Asahiro Morishita, Kyoko Oura, Koji Fujita, Shima Mimura, Teppei Sakamoto, Takako Nomura, Joji Tani, Hirohito Yoneyama, Tsutomu Masaki. Grazoprevir/elbasvir treatment for the relapse of HCV genotype 1b infection after ledipasvir/sofosbuvir: A case report. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6207
|
| 33 |
Maggie Phillips, Jumana Abboud, Bukola Abodunde, David P. Paul, Alberto Coustasse. The Growing Problem of Hepatitis C Virus Infection. The Health Care Manager 2020; 39(1): 2 doi: 10.1097/HCM.0000000000000278
|
| 34 |
J. E. Yap, P. Jaiswal, L. Ton, R. Szynkarek, B. M. Attar, S. Gandhi. Successful treatment of chronic hepatitis C infection with crushed elbasvir/grazoprevir administered via a percutaneous endoscopic gastrostomy tube. Journal of Clinical Pharmacy and Therapeutics 2018; 43(5): 730 doi: 10.1111/jcpt.12713
|
| 35 |
Núria Esforzado, José María Morales. Hepatitis C y trasplante renal: el tiempo de la erradicación del virus ha llegado. Nefrología 2019; 39(5): 458 doi: 10.1016/j.nefro.2019.01.002
|
| 36 |
Núria Esforzado, José María Morales. Hepatitis C and kidney transplant: The eradication time of the virus has arrived. Nefrología (English Edition) 2019; 39(5): 458 doi: 10.1016/j.nefroe.2019.01.009
|
| 37 |
Matteo Castelli, Nicola Clementi, Jennifer Pfaff, Giuseppe A. Sautto, Roberta A. Diotti, Roberto Burioni, Benjamin J. Doranz, Matteo Dal Peraro, Massimo Clementi, Nicasio Mancini. A Biologically-validated HCV E1E2 Heterodimer Structural Model. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00320-7
|
| 38 |
Sebastián Marciano, Leila Haddad, Fernando Plazzotta, Ezequiel Mauro, Sergio Terraza, Sanjeev Arora, Karla Thornton, Beatriz Ríos, Carlos García Dans, Natalia Ratusnu, Liliana Calanni, José Allevato, María Ester Sirotinsky, Marcos Pedrosa, Adrián Gadano. Implementation of the ECHO® telementoring model for the treatment of patients with hepatitis C. Journal of Medical Virology 2017; 89(4): 660 doi: 10.1002/jmv.24668
|
| 39 |
Harry Chown. A comparison of machine learning algorithms for the prediction of Hepatitis C NS3 protease cleavage sites. The EuroBiotech Journal 2019; 3(4): 167 doi: 10.2478/ebtj-2019-0020
|
| 40 |
Mayssa El Raziky, Sherif Hamdy, Yasser Hamada, Nermin Mohamed Abdelaziz, Mohamed Hassany, Wahid Doss, Zeinab Zakaria. Efficacy and safety of sofosbuvir and daclatasvir in patients with chronic hepatitis C virus induced cirrhosis with Child-Pugh class B. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00174-3
|
| 41 |
Andreza Soriano Figueiredo, Elisabeth Lampe, Pedro Pereira Lira Furtado de Albuquerque, Flávia Löwen Levy Chalhoub, Ana Maria Bispo de Filippis, Livia Melo Villar, Oswaldo Gonçalves Cruz, Marcelo Alves Pinto, Jaqueline Mendes de Oliveira. Epidemiological investigation and analysis of the NS5B gene and protein variability of non-primate hepacivirus in several horse cohorts in Rio de Janeiro state, Brazil. Infection, Genetics and Evolution 2018; 59: 38 doi: 10.1016/j.meegid.2018.01.017
|
| 42 |
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses. World Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
|
| 43 |
Julia M. Grottenthaler, Christoph R. Werner, Martina Steurer, Ulrich Spengler, Thomas Berg, Cornelius Engelmann, Heiner Wedemeyer, Thomas von Hahn, Wolfgang Stremmel, Anita Pathil, Ulrich Seybold, Eckart Schott, Usha Blessin, Christoph Sarrazin, Martin-Walter Welker, Ellen Harrer, Stefan Scholten, Clemens Hinterleitner, Ulrich M. Lauer, Nisar P. Malek, Christoph P. Berg, Chen-Hua Liu. Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation. PLOS ONE 2018; 13(6): e0197544 doi: 10.1371/journal.pone.0197544
|
| 44 |
Claudia Minosse, Emanuela Giombini, Barbara Bartolini, Maria Capobianchi, Anna Garbuglia. Ultra-Deep Sequencing Characterization of HCV Samples with Equivocal Typing Results Determined with a Commercial Assay. International Journal of Molecular Sciences 2016; 17(10): 1679 doi: 10.3390/ijms17101679
|
| 45 |
Amy B. Jessop, Sarah Bauerle Bass, Jesse Brajuha, Mohammed Alhajji, Monika Burke, Muhamed Tahar Gashat, Carine Wellington, Nicole Ventriglia, Jennie Coleman, Paul D'Avanzo. “Take Charge, Get Cured”: Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy. Journal of Substance Abuse Treatment 2020; 109: 23 doi: 10.1016/j.jsat.2019.11.001
|
| 46 |
Theogene Twagirumugabe, Gatare Swaibu, Tomas Bergström, Timothy David Walker, Jean Bosco Gahutu, Heléne Norder. Low prevalence of hepatitis C virus RNA in blood donors with anti‐hepatitis C virus reactivity in Rwanda. Transfusion 2017; 57(10): 2420 doi: 10.1111/trf.14204
|
| 47 |
Maliha Naseer, Harleen Chela, Alhareth AlJuboori. Viral Hepatitis: Chronic Hepatitis C. 2019; : 25 doi: 10.1007/978-3-030-03757-4_2
|
| 48 |
Tomo Shimizu, Takashi Sawada, Tomohide Asai, Yuka Kanetsuki, Jiro Hirota, Michihisa Moriguchi, Tomoaki Nakajima, Toru Miyazaki, Takeshi Okanoue. Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM-free AIM. Clinical Journal of Gastroenterology 2022; 15(1): 41 doi: 10.1007/s12328-021-01567-4
|
| 49 |
Sylvie Lagaye, Sonia Brun, Jesintha Gaston, Hong Shen, Ruzena Stranska, Claire Camus, Clarisse Dubray, Géraldine Rousseau, Pierre-Philippe Massault, Jerôme Courcambeck, Firas Bassisi, Philippe Halfon, Stanislas Pol. Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model. World Journal of Hepatology 2016; 8(21): 902-914 doi: 10.4254/wjh.v8.i21.902
|
| 50 |
Aldo Bonaventura, Fabrizio Montecucco. Sofosbuvir/velpatasvir: A promising combination. World Journal of Hepatology 2016; 8(19): 785-789 doi: 10.4254/wjh.v8.i19.785
|
| 51 |
Nagraj Mani, Andrew G. Cole, Janet R. Phelps, Andrzej Ardzinski, Kyle D. Cobarrubias, Andrea Cuconati, Bruce D. Dorsey, Ellen Evangelista, Kristi Fan, Fang Guo, Haitao Guo, Ju-Tao Guo, Troy O. Harasym, Salam Kadhim, Steven G. Kultgen, Amy C. H. Lee, Alice H. L. Li, Quanxin Long, Sara A. Majeski, Richeng Mao, Kevin D. McClintock, Stephen P. Reid, Rene Rijnbrand, Nicholas M. Snead, Holly M. Micolochick Steuer, Kim Stever, Sunny Tang, Xiaohe Wang, Qiong Zhao, Michael J. Sofia. Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation. Antimicrobial Agents and Chemotherapy 2018; 62(6) doi: 10.1128/AAC.00082-18
|
| 52 |
CALEB STOKES, ANN J. MELVIN. Avery's Diseases of the Newborn. 2024; : 450 doi: 10.1016/B978-0-323-82823-9.00034-9
|
| 53 |
Veronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens, Yot Teerawattananon, Ellen F M 't Hoen, Anita K Wagner, Prashant Yadav, Michael R Reich. Essential medicines for universal health coverage. The Lancet 2017; 389(10067): 403 doi: 10.1016/S0140-6736(16)31599-9
|
| 54 |
Mark R. Schleiss, Ketzela J. Marsh. Avery's Diseases of the Newborn. 2018; : 482 doi: 10.1016/B978-0-323-40139-5.00037-1
|